Breast cancer is the most common
cancer in women and occurs mostly with poor outcomes. Our objective was to endow synthetic lethality to the phytoconstituent
chikusetsusaponin IVa methyl
ester (CSME, S), a special phytoconstituent from
traditional Chinese medicine (TCM), Panax japonicus, with the photodynamic agent
chlorin e6 (Ce6, C) and enhance the therapeutic efficacy against
breast cancer using cell membrane-coated
liposome nanoparticles (
liposome, L). The delivery system based on
liposomes was camouflaged by a hybrid cell membrane (RBC membrane and
cancer cell membrane, M) and RGD (R) surface modifications to improve the solubility, targeting and treatment outcomes of CSME. Our results showed the successful development of nanocomplexes with extended half-life, increased immune evasion and targeted ability at the
tumor site and good antitumor activity without side effects to normal tissue. The anti-
tumor mechanism of nanocomplexes is related to cell proliferation regulation and apoptosis induction. Overall, this drug-delivery system provides a good alternative for
breast cancer therapy using a natural active phytoconstituent.